Literature DB >> 21643675

Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats.

Darin J Knapp1, David H Overstreet, Mae Huang, Tiffany A Wills, Buddy A Whitman, Robert A Angel, Sarah E Sinnett, George R Breese.   

Abstract

RATIONALE: Stress may elevate ethanol drinking and anxiety associated with ethanol drinking. Studies to identify relevant neurobiological substrates are needed.
OBJECTIVE: To assess roles of brain regions in corticotrophin releasing factor (CRF) effects on stressor-enhanced, ethanol deprivation-induced drinking and anxiety-like behavior.
METHODS: Ethanol-preferring rats (P rats) were exposed to three cycles of a two-bottle choice paradigm with two 2-day deprivation periods that included 1 h exposure to a restraint stressor. To assess the role of CRF and to identify relevant brain regions, a CRF-1 receptor antagonist (SSR125543; 10 ug) was injected into the nucleus accumbens (NAC), amygdala (Amyg), or dorsal raphe nucleus (DRN) prior to exposure to the restraint stressor. In a second study, CRF (0.5 ug) was injected into one of these regions, or the ventral tegmental area (VTA), or paraventricular nucleus of the hypothalamus (PVN).
RESULTS: Applying the restraint stressor during deprivation increased voluntary intake and sensitized anxiety-like behavior. Antagonist injection into the NAC prevented increased drinking without affecting anxiety-like behavior, whereas injection into the Amyg or DRN prevented the anxiety-like behavior without affecting drinking. To confirm CRF actions in the stressor effect, CRF was injected into selected brain regions. NAC injections (but not the VTA, Amyg, DRN, or PVN) facilitated drinking but did not change anxiety-like behavior. Injections into the DRN or Amyg (but not PVN or VTA) enhanced anxiety-like behavior.
CONCLUSIONS: Results emphasize that a restraint stressor elevates ethanol intake and sensitizes ethanol deprivation-induced anxiety-like behavior through CRF1 receptors in the NAC and Amyg/DRN, respectively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643675     DOI: 10.1007/s00213-011-2366-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  72 in total

1.  Development of an alcohol-deprivation effect in rats.

Authors:  J D Sinclair; R J Senter
Journal:  Q J Stud Alcohol       Date:  1968-12

2.  Differential sensitivity of c-Fos expression in hippocampus and other brain regions to moderate and low doses of alcohol.

Authors:  A E Ryabinin; J R Criado; S J Henriksen; F E Bloom; M C Wilson
Journal:  Mol Psychiatry       Date:  1997-01       Impact factor: 15.992

Review 3.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

4.  Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats.

Authors:  Christopher A Lowry; Matthew W Hale; Andrea Plant; Richard J Windle; Nola Shanks; Susan A Wood; Colin D Ingram; Kenneth J Renner; Stafford L Lightman; Cliff H Summers
Journal:  Stress       Date:  2009-05       Impact factor: 3.493

5.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors:  S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

6.  A comparative study on alcohol-preferring rat lines: effects of deprivation and stress phases on voluntary alcohol intake.

Authors:  Valentina Vengeliene; Sören Siegmund; Manfred V Singer; John David Sinclair; Ting-Kai Li; Rainer Spanagel
Journal:  Alcohol Clin Exp Res       Date:  2003-07       Impact factor: 3.455

Review 7.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

Review 8.  Stress and alcohol interaction: an update of human research.

Authors:  L A Pohorecky
Journal:  Alcohol Clin Exp Res       Date:  1991-06       Impact factor: 3.455

9.  The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress.

Authors:  Darin J Knapp; David H Overstreet; Robert A Angel; Montserrat Navarro; George R Breese
Journal:  Alcohol Clin Exp Res       Date:  2007-09-26       Impact factor: 3.455

10.  Differential effects of ethanol in the nucleus accumbens shell of alcohol-preferring (P), alcohol-non-preferring (NP) and Wistar rats: a proteomics study.

Authors:  William J McBride; Jonathan A Schultz; Mark W Kimpel; Jeanette N McClintick; Mu Wang; Jinsam You; Zachary A Rodd
Journal:  Pharmacol Biochem Behav       Date:  2009-01-06       Impact factor: 3.533

View more
  15 in total

Review 1.  Corticotropin releasing factor: a key role in the neurobiology of addiction.

Authors:  Eric P Zorrilla; Marian L Logrip; George F Koob
Journal:  Front Neuroendocrinol       Date:  2014-01-20       Impact factor: 8.606

Review 2.  CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Authors:  Kristen E Pleil; Mary Jane Skelly
Journal:  Alcohol       Date:  2018-02-02       Impact factor: 2.405

Review 3.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

4.  Functional alterations in the dorsal raphe nucleus following acute and chronic ethanol exposure.

Authors:  Emily G Lowery-Gionta; Catherine A Marcinkiewcz; Thomas L Kash
Journal:  Neuropsychopharmacology       Date:  2014-08-14       Impact factor: 7.853

Review 5.  The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

Authors:  Matthew B Pomrenze; Tracy L Fetterly; Danny G Winder; Robert O Messing
Journal:  Alcohol Clin Exp Res       Date:  2017-10-25       Impact factor: 3.455

Review 6.  Hypothalamic neuropeptide signaling in alcohol addiction.

Authors:  Jessica R Barson; Sarah F Leibowitz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-14       Impact factor: 5.067

7.  Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring rats.

Authors:  Weidong Yong; John Paul Spence; Robert Eskay; Stephanie D Fitz; Ruslan Damadzic; Dongbing Lai; Tatiana Foroud; Lucinda G Carr; Anantha Shekhar; Julia A Chester; Markus Heilig; Tiebing Liang
Journal:  Alcohol Clin Exp Res       Date:  2014-03-10       Impact factor: 3.455

8.  Prevention of alcohol-heightened aggression by CRF-R1 antagonists in mice: critical role for DRN-PFC serotonin pathway.

Authors:  Isabel M Quadros; Lara S Hwa; Akiko Shimamoto; Julia Carlson; Joseph F DeBold; Klaus A Miczek
Journal:  Neuropsychopharmacology       Date:  2014-06-11       Impact factor: 7.853

Review 9.  Medications for alcohol use disorders: An overview.

Authors:  Mohammed Akbar; Mark Egli; Young-Eun Cho; Byoung-Joon Song; Antonio Noronha
Journal:  Pharmacol Ther       Date:  2017-12-02       Impact factor: 12.310

10.  Transient increase in alcohol self-administration following a period of chronic exposure to corticosterone.

Authors:  Joyce Besheer; Kristen R Fisher; Tessa G Lindsay; Reginald Cannady
Journal:  Neuropharmacology       Date:  2013-05-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.